Ionis Pharmaceuticals, Inc. logo

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

Overview | Financials
Company Name Ionis Pharmaceuticals, Inc.
Symbol IONS
Currency USD
Price 32.75
Market Cap 5,212,457,250
Dividend Yield 0%
52-week-range 23.95 - 52.34
Industry Biotechnology
Sector Healthcare
CEO Dr. Brett P. Monia Ph.D.
Website https://www.ionispharma.com

An error occurred while fetching data.

About Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial

Related Stocks

Azenta, Inc. logo

Azenta, Inc.

AZTA

27.71 USD

Intra-Cellular Therapies, Inc. logo

Intra-Cellular Therapies, Inc.

ITCI

131.87 USD

Option Care Health, Inc. logo

Option Care Health, Inc.

OPCH

31.7 USD

HealthEquity, Inc. logo

HealthEquity, Inc.

HQY

91.33 USD

Integra LifeSciences Holdings Corporation logo

Integra LifeSciences Holdings Corporation

IART

12.89 USD

Omnicell, Inc. logo

Omnicell, Inc.

OMCL

25.39 USD

10x Genomics, Inc. logo

10x Genomics, Inc.

TXG

8.63 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

Financials

Numbers are in millions USD

Numbers are in millions USD